U.S. Leisure Stock News

Viatris Inc. recently received U.S. Food and Drug Administration approval for Gwyn Lo, a once-weekly low-estrogen combined hormonal contraceptive patch for women with a body mass index below 30 kg/m², supported by Phase 3 data showing contraceptive efficacy, a well-characterized safety profile and strong patch adhesion. By adding a low-dose, non-invasive, weekly contraceptive option that targets women seeking convenience and reversibility, Viatris is broadening its branded and complex...

International Paper has delivered a 33.3% gain over the past three years, yet the stock still screens as undervalued on key valuation checks, which puts the recent price moves and containerboard news in sharp focus for investors. A 33.3% return over three years suggests International Paper has already rewarded patient shareholders. The question is whether the current price still leaves room for further upside or now embeds much of that progress. Recent containerboard price increase plans and...

Investors are watching Tarsus Pharmaceuticals (TARS) ahead of its upcoming quarterly report, with expectations for a loss alongside higher revenue compared with last year and a cautious Zacks Rank of #4. See our latest analysis for Tarsus Pharmaceuticals. At a share price of US$58.52, Tarsus Pharmaceuticals has seen its share price decline 27.6% year to date, even though the 1 year total shareholder return is 46.3%. This suggests long term holders are still sitting on strong gains despite...

Consumer lending stocks are feeling the strain as the Federal Reserve holds rates steady and energy driven inflation keeps household budgets tight. With borrowing costs elevated and credit cards, auto loans, and mortgages all putting pressure on consumers, some companies exposed to this news are facing tougher conditions than others. This article focuses on three consumer lending stocks that appear more vulnerable to the current rate and inflation backdrop. Each section explains how the...

Why Teleflex Stock Is Back in Focus After EZPLAZ FDA Approval Teleflex (TFX) is drawing fresh attention after the U.S. Food and Drug Administration approved EZPLAZ Freeze Dried Plasma, the first FDA licensed freeze dried plasma product for urgent bleeding situations. The approval gives Teleflex its first biologics license for a blood component and introduces a plasma option designed for environments where traditional frozen products are hard to store or prepare, including battlefield and...

Earlier this week, n-Lorem Foundation announced an early-stage research collaboration and exclusive global licence agreement with BioMarin Pharmaceutical to develop an investigational antisense oligonucleotide therapy for ReNU syndrome, with preclinical work underway and plans for future clinical studies. A key aspect of the deal is BioMarin’s intention to develop the medicine for broader use across the ReNU syndrome community, aiming to address an estimated 75% of cases and potentially...

Capital Clean Energy Carriers (CCEC) stock is in focus after the company reported second quarter 2026 earnings, which showed higher sales alongside slightly lower net income and earnings per share compared with the same period last year. See our latest analysis for Capital Clean Energy Carriers. At a share price of $22.72, Capital Clean Energy Carriers has logged an 8.86% 1 month share price return and an 11.32% year to date share price return. Its 1 year total shareholder return is broadly...

In July 2026, First BanCorp. reported second-quarter 2026 results showing higher net interest income of US$229.13 million and net income of US$96.15 million year-on-year, alongside lower net charge-offs of US$15.98 million, completion of a US$112.78 million share repurchase program, and affirmation of a US$0.20 quarterly dividend. Together, stronger earnings, reduced credit losses, ongoing dividends, and completed buybacks highlight how First BanCorp. is actively returning capital while...

Wingstop stock has fallen 61.9% over the past year, yet the current checks send mixed signals on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) approach pointing to upside while earnings based multiples screen the shares as expensive. Recent news around soft same store sales and loyalty driven promotions adds another layer to how investors may think about what a fair price for Wingstop looks like today. Wingstop is down 61.9% over the last year, which puts the...

Recently, Stephens & Co. initiated research coverage on H&R Block with an Equal-Weight rating, adding another institutional voice to the tax preparer’s analyst following. This new coverage lands after past strong earnings and guidance raised in May, potentially sharpening investor focus on the company’s defensive profile and relative valuation. Next, we’ll examine how this fresh analyst coverage and heightened visibility may influence H&R Block’s broader investment narrative. Capitalize on...

Investor attention around Dave (DAVE) has picked up ahead of the upcoming August 5 earnings report, with expectations focused on higher earnings and revenues and the possibility that results could exceed current market estimates. See our latest analysis for Dave. Despite the recent pullback, with a 1 day share price return down 6.76% and a 7 day share price return down 10.54%, Dave still shows strong momentum, with a 90 day share price return of 39.34% and a 1 year total shareholder return of...

Earlier this week, analysts highlighted that Trex Company is expected to report a year-over-year earnings decline on higher revenues for the June 2026 quarter, with consensus EPS estimates revised upward over the past month but still pointing to weaker profitability. An interesting wrinkle is that Trex currently carries a top-tier Zacks Rank alongside a negative Earnings ESP, underscoring how diverging analyst signals are sharpening attention on the upcoming results. Next, we’ll examine how...

Strategic Education (STRA) drew fresh attention on July 29, 2026, after reporting second quarter earnings and confirming a regular quarterly cash dividend of $0.60 per share for shareholders. See our latest analysis for Strategic Education. The earnings surprise appears to have shifted sentiment toward Strategic Education, with a 7.65% 1-day share price return and 16.83% 7-day share price return, while the 1-year total shareholder return of 21.76% points to momentum building rather than...

Inflation, central bank decisions and energy prices are keeping markets on edge, which makes it harder to rely on short term signals. Founder led companies offer a different anchor. These leaders often have reputations, wealth and careers tied directly to the long term outcome of their stock. The Founder-Led Companies screener focuses on this alignment. It does not track a single sector or story, which can help you stay flexible as conditions change. In this article you will see three stocks...

Omega Healthcare Investors has delivered a strong 115.8% total return over the past five years, and the latest valuation work suggests the stock may still trade below an estimate of intrinsic value based on Discounted Cash Flow, rather than looking stretched after that run. A 115.8% return over five years suggests long term holders in Omega Healthcare Investors have already been well rewarded. Any further upside case now rests on whether the current price still leaves a margin against...

Marex Group (MRX) stock has drawn attention after recent trading performance, with the price closing at US$63.14. Investors are weighing this move against the company’s latest financial metrics and business mix. See our latest analysis for Marex Group. For context, Marex Group’s recent pullback, with a 1-day share price return of 1.59% lower and 7-day share price return of 4.12% lower, comes after strong momentum. This includes a 30-day share price return of 7.13%, a 90-day share price return...

Upstart Holdings (NasdaqGS:UPST) announced a new multi-year forward-flow loan agreement with Castlelake. The program totals up to US$4b in committed funding capacity for Upstart-powered loans. This is the largest forward-flow program between Upstart and Castlelake so far. Upstart Holdings operates an AI-driven lending platform that connects consumers, banks and credit unions. Access to committed funding is central for a company that depends on third-party capital providers to purchase and...

Atlassian stock has staged a sharp short term rebound but sits on a long stretch of weak returns, which contrasts with valuation checks that currently lean toward the shares looking cheap on several standard measures. Over the past 5 years, Atlassian has delivered a cumulative decline of 69.4%, which frames today’s share price near US$104 as a recovery off a much lower base rather than a long run success story. Expectations around Atlassian’s ability to convert its software revenue into...

US cybersecurity stocks sit at the crossroads of two powerful forces. On one side are rising concerns about AI being misused in hacks and cross border data theft. On the other are signs that regulators may tighten control of high risk AI tools after recent OpenAI related incidents. That mix can pressure some AI heavy giants while potentially giving select security focused players a relative edge. This article looks at 3 US cybersecurity stocks from the screener that appear closely exposed to...

In late July 2026, several law firms announced class action lawsuits against PROCEPT BioRobotics alleging that an undisclosed discount program led customers to buy handpiece units in volumes that materially exceeded procedure demand, inflating reported U.S. sales and creating more than 10,000 excess units of field inventory by the end of 2025. The complaints also claim PROCEPT’s guidance for 2025 lacked a reasonable factual basis because management allegedly knew pulled-forward sales and...

Boston Scientific stock has fallen about 56.9% over the past year, yet the valuation checks still lean supportive, which raises the question of whether the share price has moved further than the fundamentals suggest. The roughly 56.9% decline over the last 12 months means existing shareholders have taken a heavy hit, while potential new buyers are looking at a much lower entry point. The global restructuring plan that targets lower ongoing costs can support valuation over time. However, the...

UiPath (PATH) continues to draw attention after recent trading left the stock at a last close of US$12.59. Investors are weighing its automation platform, international footprint and current share performance across different timeframes. See our latest analysis for UiPath. The recent 1 day share price return of 3.28% and 7 day share price return of 17.66% sit against a year to date share price decline of 20.72%, while the 1 year total shareholder return of 4.83% points to mixed but improving...

WillScot Holdings recently expanded its Clearspan portfolio by launching the Quick-Connect Canopy, a rapidly deployable, ISO-mounted fabric structure that creates covered workspace between compatible modular units, now available across select major U.S. markets. This product introduces a new way for customers to integrate modular buildings, storage containers and ground-level offices into weather-protected, workflow-optimized compounds for construction, industrial and event operations. Next,...

In July 2026, NextNav Inc. announced an agreement with Safran Electronics & Defense to integrate and test interoperability between NextNav's terrestrial 5G Positioning, Navigation, and Timing network in Santa Clara County and Safran’s timing and navigation receiver for mission-critical uses such as drones, autonomous systems, critical infrastructure, and public safety. The collaboration highlights how 5G-powered 3D PNT signals could act as a complementary, more resilient layer alongside GPS...